Protein chemistry / Proteomics

Lab equipment
#Drug discovery #High throughput screening #Protein chemistry / Proteomics #Webinar

Advancing protein analysis with high-throughput multiplexed fluorescence westerns

In this webinar, hosted by DDW, Bio-Techne unveils the next evolution of the Leo System, expanding the capabilities of Simple Western Technology for high-throughput protein analysis. The Leo System now supports integrated dual fluorescence channels—Near-Infrared (NIR) and Infrared (IR)—alongside chemiluminescence, enabling simultaneous detection of multiple targets within 96 samples in… Read More

Webinar date:
Supported by Bio-Techne
#Webinars

Neuroscience innovation
#Ageing #Mass spectrometry / NMR #Neuroscience #Protein chemistry / Proteomics #Proteomics

Deciphering proteome alterations in neurodegeneration with mass spectrometry 

Daniel Hornburg PhD, Vice-President Biomarkers & Precision Medicine, Bruker Daltonics, Stefan Foser, Vice President Global Pharma, Bruker Daltonics, and Torsten Müller, Business Development Manager, Proteomics, Bruker Daltonics, explore how MS-based proteomics can be used to dissect disease biology with spatial resolution.   Impact of neurodegeneration for ageing societies Neurological conditions have… Read More

#Exclusive Content

#Collaboration #Immunology / Virology & Vaccines #Longevity #Partnership #Protein chemistry / Proteomics #RNA sequencing

New DDW Highlights podcast: 22 April 2025

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates. In a week of financial uncertainty for the industry, our round-up focuses on the… Read More

#News

#Collaboration #Immunology / Virology & Vaccines #Longevity #Partnership #Protein chemistry / Proteomics #RNA sequencing

This week in drug discovery (14-18 April) 

News round-up for 14-18 April by DDW Senior Digital Content Editor Diana Spencer. In a week of financial uncertainty for the industry, our round-up focuses on the power of partnership to accelerate drug discovery, from the prevention of respiratory infections, to mapping gene activity in inflammatory bowel disease. Read More

#News

3D protein molecules structure
#Cell and protein analysis #Drug discovery #Nuclera #Protein chemistry / Proteomics

Nuclera expands eProtein Discovery capabilities

Nuclera has announced the addition of a new membrane protein workflow to its benchtop eProtein Discovery system.   The company says this addition will allow the expression, purification and stabilisation of challenging membrane proteins, which are often key targets in therapeutic development.   Using cell-free protein synthesis,… Read More

#News

#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Synthetic DNA for protein screening in a cell-free system

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Register now: Synthesised DNA for protein screening

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Successfully express high-quality synthetic DNA in TXTL systems

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA #Webinar

Webinar: Ensure rapid, efficient and streamlined in vitro workflows

A new webinar is now open for registration entitled ‘Using ENFINIA cell-free synthesised DNA for rapid protein expression and screening in the myTXTL cell-free system‘. Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven… Read More

Webinar date:
Supported by Elegen Bio
#News

Synthetic DNA
#Drug discovery #Protein chemistry / Proteomics #Protein engineering #Synthetic biology #Synthetic DNA

Using ENFINIA™ cell-free synthesised DNA for rapid protein expression and screening in the myTXTL® cell-free system

Cell-free transcription-translation (TXTL) systems can be used for rapid and flexible protein expression and screening workflows, powering protein engineering and discovery, synthetic biology, AI-driven approaches, biomanufacturing, and more. However, reliance on plasmid DNA templates for expression requires time-consuming cloning steps, limiting speed and efficiency. In this webinar, supported by Elegen,… Read More

Webinar date:
Supported by Elegen
#Webinars

#Fc-Fusion proteins #Manufacturing #Protein chemistry / Proteomics #Whitepaper

Whitepaper: Accelerate Fab and Fc-Fusion protein development

A new whitepaper is now available from Lonza Biologics entitled ‘A Comprehensive and Flexible Approach to CMC for Fab and Fc-Fusion Development Programs‘. Download the whitepaper to learn more about: Comprehensive CMC Solutions: Explore integrated Chemistry, Manufacturing, and Controls (CMC) strategies tailored to the unique challenges of Fab and… Read More

#News

#Fc-Fusion proteins #Manufacturing #Protein chemistry / Proteomics

Accelerating CMC Strategies for Fab and Fc-Fusion Protein Development

Download the whitepaper to learn more about: Comprehensive CMC Solutions: Explore integrated Chemistry, Manufacturing, and Controls (CMC) strategies tailored to the unique challenges of Fab and Fc-Fusion protein development. Overcoming Complexity: Learn how flexible approaches can streamline the development of complex protein formats, ensuring robust and scalable manufacturing processes. Accelerating Development… Read More

#Resources

Cancer cells
#Cancer research #CAR-T #Gene mutation #Genetics / genomics #Immunotherapy #Interview #Mass spectrometry / NMR #Meet the Researcher #Nautilus #Oncology #Precision medicine #Protein chemistry / Proteomics #Rare cancers

Podcast: New ways of looking at effective cancer treatment

This is the latest episode of the free DDW narrated podcast, titled “New ways of looking at effective cancer treatment”, which covers three articles written for DDW Volume 24 – Issue 2, Spring 2023 of DDW. They are called: “3D Genomics and targeted cancer therapies”, “Democratising… Read More

#News

Baker, Hassabis and Jumper
#Chemistry #Nobel Prize #Protein chemistry / Proteomics

Nobel Prize awarded for protein design and structure innovations

The Royal Swedish Academy of Sciences has decided to award the 2024 Nobel Prize in Chemistry with one half to David Baker, University of Washington “for computational protein design”, and the other half jointly to Demis Hassabis and John Jumper, Google DeepMind, London, UK “for protein structure prediction”. Read More

#News

Antibody binding to the fusion protein of the respiratory syncytial virus
#Drug discovery #Fc-Fusion proteins #Protein chemistry / Proteomics #Therapeutic proteins #Whitepaper

Whitepaper: CMC for Fab and Fc-fusion development programmes

A new whitepaper is now available from Lonza Biologics entitled ‘A comprehensive and flexible approach to CMC for Fab and Fc-fusion development programs’. Read the whitepaper to: Gain insights into the diverse and complex structures of new molecular formats, often encompassing multiple chains and multiple domains Understand… Read More

#News

Lonza Biologics white paper
#Drug discovery #Fc-Fusion proteins #Protein chemistry / Proteomics #Therapeutic proteins

A comprehensive and flexible approach to CMC for Fab and Fc-fusion development programs

Read this whitepaper to: Gain insights into the diverse and complex structures of new molecular formats, often encompassing multiple chains and multiple domains Understand the unique challenges faced during the process development and manufacture of these advanced proteins Explore how characterising these products and developing robust manufacturing processes can help… Read More

#Resources